Zobrazeno 1 - 10
of 121
pro vyhledávání: '"low disease activity state"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveTo collect real-world data regarding the attainment of the early-achieved lupus low disease activity state (LLDAS) in systemic lupus erythematosus (SLE) patients receiving telitacicept or belimumab treatment, and identify factors predictive
Externí odkaz:
https://doaj.org/article/9d0386e627774389bff14c672884dee8
Autor:
Xi Xi Yu, Jia Deng, Qiu Xia Chen, Shi Yuan Qiu, Chao Hui Jiang, Yi Qian Wu, Qin Yang, Gao Fu Zhang, Hai Ping Yang, Fei Zhao, Qiu Li, Ai Hua Zhang, Mo Wang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundThis study aims to explore the clinical value of low disease activity state (LDAS) in the treat-to-target strategy of pediatric systemic lupus erythematosus (pSLE) and find the risk factors for never reaching LDAS.MethodsA total of 272 chil
Externí odkaz:
https://doaj.org/article/5b941eea042f4ac8b496d3b1cd3a804e
Autor:
Bergkamp, Sandy C. a, ⁎, Kanagasabapathy, Thipa a, Gruppen, Mariken P. a, Kuijpers, Taco W. a, Rashid, Amara Nassar - Sheikh a, b, van den Berg, J. Merlijn a, Schonenberg-Meinema, Dieneke a
Publikováno v:
In Clinical Immunology May 2024 262
Autor:
Zheng, Jian 1, Zhu, Li 1, Ju, Bomiao, Zhang, Jing, Luo, Jing, Wang, Yanhua, Lv, XiaoHong, Pu, Dan, He, Lan ⁎, Wang, Jing ⁎
Publikováno v:
In Clinical Immunology December 2022 245
Autor:
Ko, Tina a, 1, Koelmeyer, Rachel b, 1, Li, Ning b, Yap, Kristy a, Yeo, Ai Li a, Kent, Joanna c, Pellicano, Rebecca c, Golder, Vera a, b, Kitching, A. Richard a, b, Morand, Eric a, b, Hoi, Alberta a, b, ⁎
Publikováno v:
In Seminars in Arthritis and Rheumatism December 2022 57
2022 Systemic lupus erythematosus remission in clinical practice. Message for Polish rheumatologists
Publikováno v:
Rheumatology, Vol 60, Iss 2, Pp 125-132 (2022)
Systemic lupus erythematosus (SLE) is a complicated multiorgan disease and can lead to organ damage and increased risk of morbidity and mortality. The strategy of management while avoiding complications, especially caused by chronic glucocorticoid th
Externí odkaz:
https://doaj.org/article/3475b6090691497abbbce995860257d5
Autor:
Hoi, Alberta Y. a, b, Morand, Eric F. a, b, ∗
Publikováno v:
In Rheumatic Disease Clinics of North America August 2021 47(3):513-530
Autor:
Fangfang Sun, Huaxiang Wu, Zitao Wang, Tong Wu, Xue Wu, Jie Chen, Danting Zhang, Chunde Bao, Nan Shen, Lijun Wu, Jing Zhu, Shuang Ye
Publikováno v:
Biomedicines, Vol 11, Iss 3, p 962 (2023)
Objective: The effectiveness and safety of belimumab in Chinese lupus patients with different disease activities were investigated in a real-world setting. Method: Patients who received 10 mg/kg belimumab intravenously on weeks 0, 2, and 4, and then
Externí odkaz:
https://doaj.org/article/c6b769bbe36e4560a11b770fa9bd071e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.